1. Home
  2. LTC vs ANIP Comparison

LTC vs ANIP Comparison

Compare LTC & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LTC Properties Inc.

LTC

LTC Properties Inc.

HOLD

Current Price

$38.38

Market Cap

1.9B

Sector

Real Estate

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$74.52

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTC
ANIP
Founded
1992
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
1994
1999

Fundamental Metrics

Financial Performance
Metric
LTC
ANIP
Price
$38.38
$74.52
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$39.00
$110.00
AVG Volume (30 Days)
337.3K
344.9K
Earning Date
05-04-2026
05-08-2026
Dividend Yield
5.88%
N/A
EPS Growth
23.53
419.23
EPS
2.52
3.32
Revenue
$262,854,000.00
$206,547,000.00
Revenue This Year
N/A
$19.88
Revenue Next Year
$13.24
$15.77
P/E Ratio
$15.35
$22.32
Revenue Growth
25.26
2.47
52 Week Low
$31.70
$56.71
52 Week High
$40.80
$99.50

Technical Indicators

Market Signals
Indicator
LTC
ANIP
Relative Strength Index (RSI) 45.78 46.21
Support Level $34.13 $72.43
Resistance Level $40.05 $85.12
Average True Range (ATR) 0.71 2.57
MACD -0.17 0.11
Stochastic Oscillator 22.64 56.07

Price Performance

Historical Comparison
LTC
ANIP

About LTC LTC Properties Inc.

LTC Properties Inc is a real estate investment trust. It invests in seniors housing and health care properties, mainly through ownership, sale-leasebacks, mortgage financing, joint ventures, construction financing, and structured finance solutions, including preferred equity, bridge, and mezzanine lending. The company's investment portfolio comprises several properties located throughout the USA, the majority of which are seniors housing and skilled nursing properties. The firm conducts and manages its business as two operating segments: Real Estate Investments, which generates maximum revenue, and SHOP.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: